Learn more about the best practice use of new oral anticoagulants (NOACs) in preventing stroke and thromboembolic events in patients with non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE).
This is an opportunity to learn best practice from an expert faculty directly involved in developing the module, including Dr Andrew Sindone, Dr David Lim, and Professor Christopher Ward. The multi-modal learning approach, incorporates slide content, expert video vignettes, interactive case studies, and quizzes.
Why is this education important?
- Learn how to identify signs and symptoms of AF and VTE so that you can better distinguish other differential diagnoses
- Improve patient safety by being able to identify risk factors that put patients with AF and VTE at risk of stroke and bleeding
- Develop appropriate systems to ensure effective management of AF and VTE patients on anticoagulants by gaining a greater understanding of the role of NOACs in the management of AF and VTE.